0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Computational Immunology Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26F2205
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Computational Immunology Market Insights and Forecast to 2028
BUY CHAPTERS

Global Computational Immunology Market Research Report 2025

Code: QYRE-Auto-26F2205
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Computational Immunology Market

The global market for Computational Immunology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field"s main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
North American market for Computational Immunology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Computational Immunology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Computational Immunology in Allergy Prediction Databases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Computational Immunology include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Computational Immunology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Immunology.
The Computational Immunology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Computational Immunology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Immunology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Computational Immunology Market Report

Report Metric Details
Report Name Computational Immunology Market
Segment by Type
  • Cancer Diagnosis & Therapy
  • Reverse Vaccinology
  • Immune System Modeling
Segment by Application
  • Allergy Prediction Databases
  • Analysis Resource Database
  • International Immunogenetics System
  • The Ontology of Immune Epitopes
  • Immune Epitope Database
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Computational Immunology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Immunology Market report?

Ans: The main players in the Computational Immunology Market are EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co

What are the Application segmentation covered in the Computational Immunology Market report?

Ans: The Applications covered in the Computational Immunology Market report are Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System, The Ontology of Immune Epitopes, Immune Epitope Database

What are the Type segmentation covered in the Computational Immunology Market report?

Ans: The Types covered in the Computational Immunology Market report are Cancer Diagnosis & Therapy, Reverse Vaccinology, Immune System Modeling

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Computational Immunology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Immunology Market Perspective (2020-2031)
2.2 Global Computational Immunology Growth Trends by Region
2.2.1 Global Computational Immunology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Computational Immunology Historic Market Size by Region (2020-2025)
2.2.3 Computational Immunology Forecasted Market Size by Region (2026-2031)
2.3 Computational Immunology Market Dynamics
2.3.1 Computational Immunology Industry Trends
2.3.2 Computational Immunology Market Drivers
2.3.3 Computational Immunology Market Challenges
2.3.4 Computational Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Immunology Players by Revenue
3.1.1 Global Top Computational Immunology Players by Revenue (2020-2025)
3.1.2 Global Computational Immunology Revenue Market Share by Players (2020-2025)
3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Computational Immunology Revenue
3.4 Global Computational Immunology Market Concentration Ratio
3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2024
3.5 Global Key Players of Computational Immunology Head office and Area Served
3.6 Global Key Players of Computational Immunology, Product and Application
3.7 Global Key Players of Computational Immunology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Immunology Breakdown Data by Type
4.1 Global Computational Immunology Historic Market Size by Type (2020-2025)
4.2 Global Computational Immunology Forecasted Market Size by Type (2026-2031)
5 Computational Immunology Breakdown Data by Application
5.1 Global Computational Immunology Historic Market Size by Application (2020-2025)
5.2 Global Computational Immunology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Computational Immunology Market Size (2020-2031)
6.2 North America Computational Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Computational Immunology Market Size by Country (2020-2025)
6.4 North America Computational Immunology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Immunology Market Size (2020-2031)
7.2 Europe Computational Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Computational Immunology Market Size by Country (2020-2025)
7.4 Europe Computational Immunology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Immunology Market Size (2020-2031)
8.2 Asia-Pacific Computational Immunology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Computational Immunology Market Size by Region (2020-2025)
8.4 Asia-Pacific Computational Immunology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Immunology Market Size (2020-2031)
9.2 Latin America Computational Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Computational Immunology Market Size by Country (2020-2025)
9.4 Latin America Computational Immunology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Immunology Market Size (2020-2031)
10.2 Middle East & Africa Computational Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Computational Immunology Market Size by Country (2020-2025)
10.4 Middle East & Africa Computational Immunology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Details
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Computational Immunology Introduction
11.1.4 EpiVax Revenue in Computational Immunology Business (2020-2025)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Details
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Computational Immunology Introduction
11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2020-2025)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Details
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Computational Immunology Introduction
11.3.4 ioGenetics Revenue in Computational Immunology Business (2020-2025)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Details
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Computational Immunology Introduction
11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2020-2025)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Details
11.5.2 IMGT Business Overview
11.5.3 IMGT Computational Immunology Introduction
11.5.4 IMGT Revenue in Computational Immunology Business (2020-2025)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Immunology Introduction
11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2020-2025)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Details
11.7.2 Certara Business Overview
11.7.3 Certara Computational Immunology Introduction
11.7.4 Certara Revenue in Computational Immunology Business (2020-2025)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Details
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Computational Immunology Introduction
11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2020-2025)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Details
11.9.2 Compugen Business Overview
11.9.3 Compugen Computational Immunology Introduction
11.9.4 Compugen Revenue in Computational Immunology Business (2020-2025)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Details
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Computational Immunology Introduction
11.10.4 Genedata AG Revenue in Computational Immunology Business (2020-2025)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Details
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Computational Immunology Introduction
11.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2020-2025)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Details
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Computational Immunology Introduction
11.12.4 Leadscope Inc Revenue in Computational Immunology Business (2020-2025)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Details
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Computational Immunology Introduction
11.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2020-2025)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Computational Immunology Introduction
11.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2020-2025)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Details
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Computational Immunology Introduction
11.15.4 Schrodinger Revenue in Computational Immunology Business (2020-2025)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Details
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Computational Immunology Introduction
11.16.4 Simulation Plus Revenue in Computational Immunology Business (2020-2025)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Details
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Computational Immunology Introduction
11.17.4 Rosa & Co Revenue in Computational Immunology Business (2020-2025)
11.17.5 Rosa & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Computational Immunology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cancer Diagnosis & Therapy
 Table 3. Key Players of Reverse Vaccinology
 Table 4. Key Players of Immune System Modeling
 Table 5. Global Computational Immunology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Computational Immunology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Computational Immunology Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Computational Immunology Market Share by Region (2020-2025)
 Table 9. Global Computational Immunology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Computational Immunology Market Share by Region (2026-2031)
 Table 11. Computational Immunology Market Trends
 Table 12. Computational Immunology Market Drivers
 Table 13. Computational Immunology Market Challenges
 Table 14. Computational Immunology Market Restraints
 Table 15. Global Computational Immunology Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Computational Immunology Market Share by Players (2020-2025)
 Table 17. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2024)
 Table 18. Ranking of Global Top Computational Immunology Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Computational Immunology Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Computational Immunology, Headquarters and Area Served
 Table 21. Global Key Players of Computational Immunology, Product and Application
 Table 22. Global Key Players of Computational Immunology, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Computational Immunology Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Computational Immunology Revenue Market Share by Type (2020-2025)
 Table 26. Global Computational Immunology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Computational Immunology Revenue Market Share by Type (2026-2031)
 Table 28. Global Computational Immunology Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Computational Immunology Revenue Market Share by Application (2020-2025)
 Table 30. Global Computational Immunology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Computational Immunology Revenue Market Share by Application (2026-2031)
 Table 32. North America Computational Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Computational Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Computational Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Computational Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Computational Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Computational Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Computational Immunology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Computational Immunology Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Computational Immunology Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Computational Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Computational Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Computational Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Computational Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Computational Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Computational Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 47. EpiVax Company Details
 Table 48. EpiVax Business Overview
 Table 49. EpiVax Computational Immunology Product
 Table 50. EpiVax Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 51. EpiVax Recent Development
 Table 52. Novozymes Biopharma Company Details
 Table 53. Novozymes Biopharma Business Overview
 Table 54. Novozymes Biopharma Computational Immunology Product
 Table 55. Novozymes Biopharma Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 56. Novozymes Biopharma Recent Development
 Table 57. ioGenetics Company Details
 Table 58. ioGenetics Business Overview
 Table 59. ioGenetics Computational Immunology Product
 Table 60. ioGenetics Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 61. ioGenetics Recent Development
 Table 62. International Society of Vaccines Company Details
 Table 63. International Society of Vaccines Business Overview
 Table 64. International Society of Vaccines Computational Immunology Product
 Table 65. International Society of Vaccines Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 66. International Society of Vaccines Recent Development
 Table 67. IMGT Company Details
 Table 68. IMGT Business Overview
 Table 69. IMGT Computational Immunology Product
 Table 70. IMGT Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 71. IMGT Recent Development
 Table 72. Dassault Systemes Company Details
 Table 73. Dassault Systemes Business Overview
 Table 74. Dassault Systemes Computational Immunology Product
 Table 75. Dassault Systemes Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 76. Dassault Systemes Recent Development
 Table 77. Certara Company Details
 Table 78. Certara Business Overview
 Table 79. Certara Computational Immunology Product
 Table 80. Certara Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 81. Certara Recent Development
 Table 82. Chemical Computing Group Company Details
 Table 83. Chemical Computing Group Business Overview
 Table 84. Chemical Computing Group Computational Immunology Product
 Table 85. Chemical Computing Group Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 86. Chemical Computing Group Recent Development
 Table 87. Compugen Company Details
 Table 88. Compugen Business Overview
 Table 89. Compugen Computational Immunology Product
 Table 90. Compugen Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 91. Compugen Recent Development
 Table 92. Genedata AG Company Details
 Table 93. Genedata AG Business Overview
 Table 94. Genedata AG Computational Immunology Product
 Table 95. Genedata AG Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 96. Genedata AG Recent Development
 Table 97. Insilico Biotechnology AG Company Details
 Table 98. Insilico Biotechnology AG Business Overview
 Table 99. Insilico Biotechnology AG Computational Immunology Product
 Table 100. Insilico Biotechnology AG Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 101. Insilico Biotechnology AG Recent Development
 Table 102. Leadscope Inc Company Details
 Table 103. Leadscope Inc Business Overview
 Table 104. Leadscope Inc Computational Immunology Product
 Table 105. Leadscope Inc Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 106. Leadscope Inc Recent Development
 Table 107. Nimbus Discovery Company Details
 Table 108. Nimbus Discovery Business Overview
 Table 109. Nimbus Discovery Computational Immunology Product
 Table 110. Nimbus Discovery Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 111. Nimbus Discovery Recent Development
 Table 112. Strand Life Sciences Company Details
 Table 113. Strand Life Sciences Business Overview
 Table 114. Strand Life Sciences Computational Immunology Product
 Table 115. Strand Life Sciences Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 116. Strand Life Sciences Recent Development
 Table 117. Schrodinger Company Details
 Table 118. Schrodinger Business Overview
 Table 119. Schrodinger Computational Immunology Product
 Table 120. Schrodinger Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 121. Schrodinger Recent Development
 Table 122. Simulation Plus Company Details
 Table 123. Simulation Plus Business Overview
 Table 124. Simulation Plus Computational Immunology Product
 Table 125. Simulation Plus Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 126. Simulation Plus Recent Development
 Table 127. Rosa & Co Company Details
 Table 128. Rosa & Co Business Overview
 Table 129. Rosa & Co Computational Immunology Product
 Table 130. Rosa & Co Revenue in Computational Immunology Business (2020-2025) & (US$ Million)
 Table 131. Rosa & Co Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Computational Immunology Picture
 Figure 2. Global Computational Immunology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Computational Immunology Market Share by Type: 2024 VS 2031
 Figure 4. Cancer Diagnosis & Therapy Features
 Figure 5. Reverse Vaccinology Features
 Figure 6. Immune System Modeling Features
 Figure 7. Global Computational Immunology Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Computational Immunology Market Share by Application: 2024 VS 2031
 Figure 9. Allergy Prediction Databases Case Studies
 Figure 10. Analysis Resource Database Case Studies
 Figure 11. International Immunogenetics System Case Studies
 Figure 12. The Ontology of Immune Epitopes Case Studies
 Figure 13. Immune Epitope Database Case Studies
 Figure 14. Computational Immunology Report Years Considered
 Figure 15. Global Computational Immunology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Computational Immunology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Computational Immunology Market Share by Region: 2024 VS 2031
 Figure 18. Global Computational Immunology Market Share by Players in 2024
 Figure 19. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Computational Immunology Revenue in 2024
 Figure 21. North America Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Computational Immunology Market Share by Country (2020-2031)
 Figure 23. United States Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Computational Immunology Market Share by Country (2020-2031)
 Figure 27. Germany Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Computational Immunology Market Share by Region (2020-2031)
 Figure 35. China Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Computational Immunology Market Share by Country (2020-2031)
 Figure 43. Mexico Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Computational Immunology Market Share by Country (2020-2031)
 Figure 47. Turkey Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Computational Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. EpiVax Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 51. Novozymes Biopharma Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 52. ioGenetics Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 53. International Society of Vaccines Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 54. IMGT Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 55. Dassault Systemes Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 56. Certara Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 57. Chemical Computing Group Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 58. Compugen Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 59. Genedata AG Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 60. Insilico Biotechnology AG Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 61. Leadscope Inc Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 62. Nimbus Discovery Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 63. Strand Life Sciences Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 64. Schrodinger Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 65. Simulation Plus Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 66. Rosa & Co Revenue Growth Rate in Computational Immunology Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS